TN2010000007A1 - 8-beta- substituted estratrienes as selectively active estrogens - Google Patents

8-beta- substituted estratrienes as selectively active estrogens

Info

Publication number
TN2010000007A1
TN2010000007A1 TNP2010000007A TN2010000007A TN2010000007A1 TN 2010000007 A1 TN2010000007 A1 TN 2010000007A1 TN P2010000007 A TNP2010000007 A TN P2010000007A TN 2010000007 A TN2010000007 A TN 2010000007A TN 2010000007 A1 TN2010000007 A1 TN 2010000007A1
Authority
TN
Tunisia
Prior art keywords
beta
selectively active
estrogen receptor
active estrogens
substituted estratrienes
Prior art date
Application number
TNP2010000007A
Other languages
English (en)
Inventor
Olaf Peters
Nico Braeuer
Ina Thieme
Katja Prelle
Hans-Peter Muhn
Karl-Heinrich Fritzemeier
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of TN2010000007A1 publication Critical patent/TN2010000007A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2010000007A 2007-07-12 2010-01-07 8-beta- substituted estratrienes as selectively active estrogens TN2010000007A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07075600A EP2014672A1 (fr) 2007-07-12 2007-07-12 Estratriènes 8 bêta substitués servant d'oestrogènes sélectivement actifs
PCT/EP2008/059115 WO2009007454A2 (fr) 2007-07-12 2008-07-11 Estratriènes à substitution 8-bêta servant d'œstrogènes sélectivement actifs

Publications (1)

Publication Number Publication Date
TN2010000007A1 true TN2010000007A1 (en) 2011-09-26

Family

ID=38657613

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000007A TN2010000007A1 (en) 2007-07-12 2010-01-07 8-beta- substituted estratrienes as selectively active estrogens

Country Status (34)

Country Link
US (1) US20090029957A1 (fr)
EP (2) EP2014672A1 (fr)
JP (1) JP2010533152A (fr)
KR (1) KR20100037593A (fr)
CN (1) CN101687902B (fr)
AR (1) AR067507A1 (fr)
AU (1) AU2008274198A1 (fr)
BR (1) BRPI0814207A2 (fr)
CA (1) CA2692727A1 (fr)
CL (1) CL2008002027A1 (fr)
CO (1) CO6270230A2 (fr)
CR (1) CR11211A (fr)
CU (1) CU23885B1 (fr)
CY (1) CY1113351T1 (fr)
DK (1) DK2176282T3 (fr)
DO (1) DOP2010000017A (fr)
EA (1) EA017124B1 (fr)
EC (1) ECSP109872A (fr)
ES (1) ES2393942T3 (fr)
HN (1) HN2010000081A (fr)
HR (1) HRP20120952T1 (fr)
MA (1) MA31565B1 (fr)
NZ (1) NZ582490A (fr)
PA (1) PA8789401A1 (fr)
PE (1) PE20090825A1 (fr)
PL (1) PL2176282T3 (fr)
PT (1) PT2176282E (fr)
RS (1) RS52541B (fr)
SI (1) SI2176282T1 (fr)
TN (1) TN2010000007A1 (fr)
TW (1) TW200911824A (fr)
UA (1) UA99918C2 (fr)
UY (1) UY31220A1 (fr)
WO (1) WO2009007454A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2688901B1 (fr) * 2011-03-25 2019-05-08 Université Laval INHIBITEURS DE 17ß-HSD1, 17ß-HSD3 ET 17ß-HSD10
EP3474965A4 (fr) * 2016-06-24 2020-02-05 K & N Engineering, Inc. Filtres à air contenant des composés et procédés associés auxdits filtres
USD905747S1 (en) 2018-04-09 2020-12-22 Mitsubishi Electric Corporation Display screen with animated graphical user interface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019167A1 (de) * 2000-04-12 2001-10-18 Schering Ag Substituierte Estratriene als selektiv wirksame Estrogene
MXPA02010066A (es) * 2000-04-12 2003-06-04 Schering Ag Estratrienos sustituidos en 8beta-hidrocarbilo para uso como estrogenos selectivos.

Also Published As

Publication number Publication date
CN101687902A (zh) 2010-03-31
HRP20120952T1 (hr) 2012-12-31
WO2009007454A3 (fr) 2009-03-05
DOP2010000017A (es) 2010-01-31
WO2009007454A2 (fr) 2009-01-15
US20090029957A1 (en) 2009-01-29
CR11211A (es) 2010-04-27
MA31565B1 (fr) 2010-08-02
EP2176282B1 (fr) 2012-08-22
AR067507A1 (es) 2009-10-14
BRPI0814207A2 (pt) 2015-01-27
AU2008274198A1 (en) 2009-01-15
ES2393942T3 (es) 2013-01-02
HN2010000081A (es) 2013-07-01
UY31220A1 (es) 2009-03-02
RS52541B (en) 2013-04-30
EP2176282A2 (fr) 2010-04-21
SI2176282T1 (sl) 2013-02-28
CL2008002027A1 (es) 2009-01-16
DK2176282T3 (da) 2012-12-03
EP2014672A1 (fr) 2009-01-14
PT2176282E (pt) 2012-11-30
PE20090825A1 (es) 2009-07-25
TW200911824A (en) 2009-03-16
PA8789401A1 (es) 2009-04-23
UA99918C2 (ru) 2012-10-25
CO6270230A2 (es) 2011-04-20
KR20100037593A (ko) 2010-04-09
CY1113351T1 (el) 2016-06-22
EA201000097A1 (ru) 2010-08-30
CU20100008A7 (es) 2011-05-27
EA017124B1 (ru) 2012-10-30
CA2692727A1 (fr) 2009-01-15
NZ582490A (en) 2012-03-30
PL2176282T3 (pl) 2013-06-28
CN101687902B (zh) 2013-07-24
CU23885B1 (es) 2013-04-19
ECSP109872A (es) 2010-02-26
JP2010533152A (ja) 2010-10-21

Similar Documents

Publication Publication Date Title
AU2001273945A1 (en) 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
NZ609420A (en) Fulvestrant compositions and methods of use
IN2012DN04867A (fr)
PE20080273A1 (es) Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico
MX338290B (es) Tratamiento de enfermedad de alzheimer, perdida de cognición, perdida de memoria y demencia con precursores de esteroides sexuales en conbinación con moduladores selectivos del receptor de estrógenos.
WO2005077968A8 (fr) Steroides destines au traitement du cancer
PE20070188A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
CU24106B1 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
PL2131847T3 (pl) Lek zawierający przynajmniej jeden gestagen
TW200716137A (en) Tanaproget compositions containing ethinyl estradiol
NZ615430A (en) Method for on-demand contraception
MY161549A (en) Progesterone antagonists such as cdb-4124 in the treatment of breast cancer
TN2010000007A1 (en) 8-beta- substituted estratrienes as selectively active estrogens
TW200612962A (en) Estriol and estetrol prodrugs
MX2008000070A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.
WO2009059806A3 (fr) Préparation d'analogues de l'œstrogène 6-oxa-8α-stéroïde - un nouveau groupe d'œstrogènes non naturels et leur utilisation en médecine
RS107004A (en) 9-alpha-substituted estratrienes as selectively active estrogen
JP2011503020A5 (fr)
TW200740778A (en) Non-steroidal progesterone receptor modulators
MX2009013305A (es) Composicion farmaceutica de un nuevo sistema para liberacion vaginal de esteroides.
TH114620A (th) 8-บีตา-ซับสทิทิวเทด เอสทราไทรอีนที่เป็นเอสโทรเจนที่ออกฤทธิ์อย่างมีอำนาจเลือก
TW200603812A (en) D-homo-17-chlor-16(17)-ene steroids